The management and prevention of vancomycin-resistant enterococci

Valentina Stosor; Gary A. Noskin; Lance R. Peterson

The management and prevention of vancomycin-resistant enterococci

Valentina Stosor^*, Gary A. Noskin, Lance R. Peterson

^*Corresponding author for this work

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Within the past 5 years, vancomycin-resistant enterococci (VRE) have swept throughout the US and Europe. Many of these organisms are also highly resistant to β-lactams and aminoglycosides, thereby making them virtually unbeatable. Optimal therapy for these infections is unknown despite extremely high mortality rates for patients with VRE bacteremia. Until effective therapy is available, prevention of transmission by adequate infection control procedures and judicious antibiotic use is critical.

Original language	English (US)
Pages (from-to)	487-488+493
Journal	Infections in Medicine
Volume	13
Issue number	6
State	Published - Jun 1 1996

Keywords

Drug resistance
Enterococci
Vancomycin

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c6e5d755f958472ab25be6bc83f8ed7d,

title = "The management and prevention of vancomycin-resistant enterococci",

abstract = "Within the past 5 years, vancomycin-resistant enterococci (VRE) have swept throughout the US and Europe. Many of these organisms are also highly resistant to β-lactams and aminoglycosides, thereby making them virtually unbeatable. Optimal therapy for these infections is unknown despite extremely high mortality rates for patients with VRE bacteremia. Until effective therapy is available, prevention of transmission by adequate infection control procedures and judicious antibiotic use is critical.",

keywords = "Drug resistance, Enterococci, Vancomycin",

author = "Valentina Stosor and Noskin, {Gary A.} and Peterson, {Lance R.}",

year = "1996",

month = jun,

day = "1",

language = "English (US)",

volume = "13",

pages = "487--488+493",

journal = "Infections in Medicine",

issn = "0749-6524",

publisher = "CMP Healthcare Media LLC",

number = "6",

}

TY - JOUR

T1 - The management and prevention of vancomycin-resistant enterococci

AU - Stosor, Valentina

AU - Noskin, Gary A.

AU - Peterson, Lance R.

PY - 1996/6/1

Y1 - 1996/6/1

N2 - Within the past 5 years, vancomycin-resistant enterococci (VRE) have swept throughout the US and Europe. Many of these organisms are also highly resistant to β-lactams and aminoglycosides, thereby making them virtually unbeatable. Optimal therapy for these infections is unknown despite extremely high mortality rates for patients with VRE bacteremia. Until effective therapy is available, prevention of transmission by adequate infection control procedures and judicious antibiotic use is critical.

AB - Within the past 5 years, vancomycin-resistant enterococci (VRE) have swept throughout the US and Europe. Many of these organisms are also highly resistant to β-lactams and aminoglycosides, thereby making them virtually unbeatable. Optimal therapy for these infections is unknown despite extremely high mortality rates for patients with VRE bacteremia. Until effective therapy is available, prevention of transmission by adequate infection control procedures and judicious antibiotic use is critical.

KW - Drug resistance

KW - Enterococci

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=0029681982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029681982&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029681982

SN - 0749-6524

VL - 13

SP - 487-488+493

JO - Infections in Medicine

JF - Infections in Medicine

IS - 6

ER -

The management and prevention of vancomycin-resistant enterococci

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this